<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Many chemotherapeutic agents induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> via a p53-dependent pathway </plain></SENT>
<SENT sid="1" pm="."><plain>However, up to 50% of human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> have p53 mutation and loss of p53 function </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="15358">Histone</z:chebi> deacetylase inhibitors (HDACIs) are emerging as a potentially important new class of anticancer agents </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we report that, <z:chebi fb="0" ids="46024">Trichostatin A</z:chebi> (TSA), a pan-HDAC inhibitor, could induce G2/M cell cycle arrest and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in both <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines with <z:mp ids='MP_0002169'>wild-type</z:mp> p53 (HT116 cells) and mutant p53 (HT29 cells), although HCT116 cells had more apoptotic cells than HT29 cells </plain></SENT>
<SENT sid="4" pm="."><plain>TSA induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in both cell lines via the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> pathway as indicated by decrease of the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane potential (MMP) and activation of caspase-3 </plain></SENT>
<SENT sid="5" pm="."><plain>Additionally, TSA induces expression of the pro-apoptotic protein Bax and decreases the expression of the anti-apoptotic proteins Bcl-2 and Bcl-xL in both cell lines </plain></SENT>
<SENT sid="6" pm="."><plain>Bax knockdown by siRNA significantly impaired TSA-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in both cell lines </plain></SENT>
<SENT sid="7" pm="."><plain>These data suggest that TSA induces G2/M cell cycle arrest and Bax-dependent <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells (HCT116 cells and HT29 cells) by both p53-dependent and -independent mechanisms </plain></SENT>
<SENT sid="8" pm="."><plain>However, cells with <z:mpath ids='MPATH_458'>normal</z:mpath> p53 function are more sensitive to TSA-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
</text></document>